Costly biologics have tormented healthcare consumers since always. Biosimilars market has come up as the best ‘alternative’ bet with their cost-effectiveness, as governments across the world try t…
This new report from Venture Planning Group provides leading chemical companies strategic directions. The report presents insightful strategic assessments, including:
- Specific business, new product development and marketing strategies.
- Strengths and weaknesses.
- Anticipated acquisitions, joint ventures and divestitures.
The companies analyzed in the report include BASF, Dow, DuPont, ExxonMobil, INEOS, Lyondell, Mitsubishi Chemical, SABIC, Shell, and Sinopec.